Navidea Biopharmaceuticals

$2.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+1.36%) Today

+$0.12 (+5.38%) As of 12:42 AM UTC after-hours

Why Robinhood?

You can buy or sell NAVB and other stocks, options, and ETFs commission-free!

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH. The listed name for NAVB is Navidea Biopharmaceuticals Inc.

CEO

Jed Andrew Latkin

Employees

Headquarters

Dublin, Ohio

Founded

1983

Market Cap

59.51M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

319.22K

High Today

$2.23

Low Today

$2.15

Open Price

$2.20

Volume

171.24K

52 Week High

$5.36

52 Week Low

$0.63

Collections

NAVB Earnings

-$0.24

-$0.16

-$0.08

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 10, After Hours